Health & Life Sciences

Overview

As a stakeholder in the health and life sciences sector, you work every day to improve human health and enhance patient care. Our national health and life sciences team partners with industry leaders like you — biotech innovators, pharmaceutical and medical device manufacturers, health systems, investors, and digital health pioneers — to help you thrive in a landscape defined by rapid change and increasingly complex regulatory demands.

Our professionals have extensive practical experience to help you navigate the sector’s most critical business and legal challenges. We advise on transformative mergers and acquisitions, strategic investments, and capital deployment, ensuring your transactions are efficient and positioned for long-term growth and innovation. Our team handles high-stakes litigation and government investigations, providing sophisticated advocacy and clear strategic guidance when challenges arise.

We support you throughout the business life cycle — structuring and negotiating technology transactions, licensing, and collaborations; guiding you through complex regulatory requirements at all stages of the product lifecycle; and implementing proactive risk management and compliance solutions. Our capabilities also encompass employee benefits and executive compensation, privacy and data security, outsourcing, intellectual property, and public policy strategy, helping you seize opportunities and mitigate risk in every aspect of your operations.

Our team includes former in-house counsel to major health systems and global life sciences companies, as well as former FDA, other federal agency and Capitol Hill health policy advisors, and former Department of Justice attorneys. With this blend of industry insight and legal acumen, we deliver practical, business-minded solutions tailored to your most complex challenges so you can continue advancing your mission and achieving your strategic objectives in a rapidly evolving sector.

Insights & Events

Latest

最新 May 2026

Multimillion-Dollar Trade Secret Verdict Reversed by Federal Circuit Due to Prior Disclosure in Patents and Self-Evident Concepts in California Case

International Medical Devices, Inc. v. Cornell, No. 25-1843 (Fed. Cir. April 17, 2026)
4 min read
最新 May 2026

New Executive Order Directs Federal Agencies to Default to Firm Fixed-Price Contracts

Agencies Directed to Limit Cost-Type Contracting and Increase Reliance on Performance-Based Considerations
5 min read
最新 May 2026

HHS Office of Inspector General Declares That Fair-Market-Value Transactions Can Be Kickbacks

FAQ 17 Was Added on April 23, 2026
3 min read
News May 2026

Faegre Drinker Represents Teva Pharmaceutical in its Agreement to Acquire Emalex Biosciences

2 min read
媒体报道 April 2026

Law Week Colorado Profiles Heather Perkins in 2026 Super Lawyers Issue

1 min read
媒体报道 April 2026

Sarah Bassler Millar Comments on New Mental Health Parity Rule in Law360

1 min read
最新 April 2026

FDA-Related Legislative and Regulatory Proposals and Funding Change the President's FY27 Budget

Between a Doorstop and a Starting Gun
121 min read
News April 2026

Jennifer Breuer Named a 2026 ‘Notable Leaders in Health Care’ Honoree by Crain’s Chicago Business

1 min read
Speaking Engagement Recap March 18, 2026

AI-Enabled Medical Devices: Navigating New Liability Risks and Regulatory Frontiers

Defense Research Institute’s Drug and Medical Device Committee Meeting
1 min read
Speaking Engagement Recap November 08, 2025

The Impact of AI on the Pharmacy Industry: Managing its Risks and Benefits

American Society for Pharmacy Law: 2025 Developments in Pharmacy Law
1 min read
Insights
最新 May 2026

Multimillion-Dollar Trade Secret Verdict Reversed by Federal Circuit Due to Prior Disclosure in Patents and Self-Evident Concepts in California Case

International Medical Devices, Inc. v. Cornell, No. 25-1843 (Fed. Cir. April 17, 2026)
4 min read
最新 May 2026

New Executive Order Directs Federal Agencies to Default to Firm Fixed-Price Contracts

Agencies Directed to Limit Cost-Type Contracting and Increase Reliance on Performance-Based Considerations
5 min read
最新 May 2026

HHS Office of Inspector General Declares That Fair-Market-Value Transactions Can Be Kickbacks

FAQ 17 Was Added on April 23, 2026
3 min read
媒体报道 April 2026

Law Week Colorado Profiles Heather Perkins in 2026 Super Lawyers Issue

1 min read
媒体报道 April 2026

Sarah Bassler Millar Comments on New Mental Health Parity Rule in Law360

1 min read
最新 April 2026

FDA-Related Legislative and Regulatory Proposals and Funding Change the President's FY27 Budget

Between a Doorstop and a Starting Gun
121 min read
最新 April 2026

Federal Court Approves Flexible Damages Approach in $70 Million Trade-Secret Verdict

Syntel Sterling Best Shores Mauritius Ltd. et al. v. The TriZetto Group Inc., No. 15-211 (S.D.N.Y. 2026)
4 min read
最新 April 2026

Minnesota PFAS Reporting: Deadline Extension and Enhanced Support

The Initial Reporting Deadline Is Extended to September 15, 2026
4 min read
发表文章 April 2026

Bankruptcy Court Dismisses Adversary Complaint Against CMS for Terminating Debtors’ Provider Status

The Legal Intelligencer
2 min read
发表文章 April 2026

Expert Witness Practice in U.S. Drug and Medical Device Litigation

International Comparative Legal Guide – Drug & Medical Device Litigation 2026
1 min read

Meet The Team

Meet The Team